Published in Cancer Immunol Immunother on January 01, 1990
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg (1992) 1.50
Whole tumor antigen vaccines. Semin Immunol (2010) 1.19
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Ann Surg (1997) 0.79
The role of cholecystectomy in acquired immunodeficiency syndrome. J Am Coll Surg (1997) 2.57
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. J Immunol (1975) 1.57
Massive localized lymphedema of the thigh in a morbidly obese patient. Eur J Surg Oncol (2009) 1.41
Adjuvant immunotherapy for patients with melanoma: are patients with melanoma of the head and neck candidates for this therapy? Head Neck (1997) 1.38
Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature. Am J Clin Oncol (2000) 1.21
Ectopic supernumerary kidney, a cause of para-aortic mass: case report and review. Am Surg (2001) 1.19
Gestational carcinoma of the female breast. Curr Probl Cancer (1983) 1.17
Cholecystectomy in the elderly. Am J Surg (1988) 1.13
Pyogenic liver abscess secondary to asymptomatic sigmoid diverticulitis. Ann Surg (1976) 1.08
Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties. Proc Natl Acad Sci U S A (1975) 1.07
Inflammatory oncotaxis after testing the skin of the cancer patient. Cancer (1981) 1.00
The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. II. Abrogation of antigen-induced suppression by selective cytotoxic agents. J Immunol (1976) 0.96
Long-term survival after locally aggressive anorectal melanoma. Am Surg (1998) 0.95
Appendicitis in patients with acquired immunodeficiency syndrome. J Am Coll Surg (1997) 0.93
Murine lymphocyte comitogenesis by phorbol esters, and its inhibition by retinoic acid and inhibitors of polyamine biosynthesis. Toxicol Appl Pharmacol (1981) 0.91
Negative appendicectomy rate as a quality metric in the management of appendicitis: impact of computed tomography, Alvarado score and the definition of negative appendicectomy. Ann R Coll Surg Engl (2012) 0.91
Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines. Cancer Res (1981) 0.88
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. Cell Immunol (1976) 0.88
A new approach in specific, active immunotherapy. Cancer (1977) 0.86
Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice. Cancer Immunol Immunother (1998) 0.85
Carcinoma of the breast during pregnancy: a review and update on treatment options. Surg Oncol (1999) 0.85
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer (1986) 0.85
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg (1986) 0.84
Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg (1987) 0.84
Coronary artery bypass grafting in patients with human immunodeficiency virus. J Card Surg (1997) 0.83
Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vitro production of a suppressor factor by peritoneal macrophages. J Reticuloendothel Soc (1980) 0.83
Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells. J Immunol (1979) 0.83
Kinetic study of T lymphocytes after sensitization against soluble antigen. III. Potentiation and suppression of the PHA response by antigen-activated lymphocytes of low density. J Exp Med (1975) 0.82
Cholecystectomy in the elderly. Am Surg (1988) 0.82
Cellular immunosenescence in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages. Mech Ageing Dev (1984) 0.81
Crohn's disease of the appendix. Surgery (1990) 0.81
A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment. J Biol Response Mod (1983) 0.81
Gastric cancer in the elderly. Am Surg (1987) 0.81
Effect of splenectomy on the growth of murine colon tumors. J Surg Oncol (1983) 0.80
Suppression of rat T cell proliferation by Corynebacterium parvum: T cell requirement for induction. J Reticuloendothel Soc (1978) 0.80
3-deazaadenosine, a transmethylase inhibitor, suppresses the effect of lipopolysaccharide on release of prostacyclin and thromboxane. J Pharm Pharmacol (1981) 0.79
Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma. J Immunother Emphasis Tumor Immunol (1994) 0.79
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case. Dis Colon Rectum (2001) 0.79
Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials. Surg Oncol (2001) 0.79
Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity. Carcinog Compr Surv (1982) 0.79
Bilateral adrenalectomy in treatment of disseminated breast cancer. Am J Surg (1976) 0.78
Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model. Cancer Immunol Immunother (1994) 0.78
The surgeon's database for AIDS: a collective review. J Am Coll Surg (1997) 0.77
The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma. Am Surg (1990) 0.77
Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma. G Ital Dermatol Venereol (2008) 0.76
Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge. J Surg Oncol (1989) 0.76
Balloon blunt-tip trocar for laparoscopic cholecystectomy: improvement over the traditional Hasson and Veress needle methods. J Laparoendosc Adv Surg Tech A (2001) 0.76
Use of epidural anesthesia and spontaneous ventilation during transabdominal colon and rectal procedures in selected high-risk patient groups. Dis Colon Rectum (1997) 0.75
Vaccinia virus oncolysates in the treatment of malignant melanoma. Cancer Treat Res (1988) 0.75
Cholecystectomy and AIDS. J Am Coll Surg (1997) 0.75
Leukotriene C stimulates prostaglandin release from rat peritoneal macrophages. Biochem Biophys Res Commun (1981) 0.75
Immunotherapy in colorectal cancer. Mo Med (1981) 0.75
Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award. Am Surg (1988) 0.75
Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2. J Surg Res (1988) 0.75
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies. J Biol Response Mod (1989) 0.75
Surgical management of melanoma. Surg Oncol (1995) 0.75
Phenotypic analysis of a human hematopoietic cell line with lymphoid and myeloid features using simultaneous multicolor flow cytometry. Transplant Proc (1997) 0.75
Cellular immunosenescence in F344 rats: decline in responsiveness to phytohemagglutinin involves changes in both T cells and macrophages. Mech Ageing Dev (1983) 0.75
A search for markers of rabbit lymphoid cells; alloantigens characterized by antisera to rabbit thymus. Int Arch Allergy Appl Immunol (1974) 0.75
Perfusion therapy for extremity melanoma. Arch Surg (1976) 0.75
Carrageenan-induced suppression of T lymphocyte proliferation in the rat: in vivo suppression induced by oral administration. J Reticuloendothel Soc (1980) 0.75
Serological evaluation of melanoma patients in a phase I/II trial of vaccinia melanoma oncolysate (VMO) immunotherapy. Cancer Detect Prev Suppl (1987) 0.75
Avoidance of anastomotic complications in low anterior resection of the rectum. Dis Colon Rectum (1997) 0.75
The treatment of cancer of the large intestine. Surg Gynecol Obstet (1976) 0.75
Cancer to the inguinal nodes from an unknown primary site. J Surg Oncol (1981) 0.75
Prospects for gene therapy and lymphokine therapy for metastatic melanoma. Ann Plast Surg (1992) 0.75
Transplantation immunity and cross-protection of two cultured murine colon lines. J Natl Cancer Inst (1983) 0.75
A new approach in immunotherapy with Vaccinia oncolysates. Surg Forum (1977) 0.75
Immunomodulatory activities of human leukocyte interferon in advanced cancer patients. J Biol Response Mod (1983) 0.75
Ligation device assisting low anterior anastomosis. Dis Colon Rectum (1995) 0.75
Gastric epithelioid leiomyoma causing intraperitoneal hemorrhage. South Med J (1986) 0.75
Neuraminidase immunotherapy: serum potentiation of lymphocyte cytotoxicity related to immunoglobulin levels. J Surg Oncol (1976) 0.75
Inhibition of macrophage-induced tumor cell cytostasis and cytolysis by tumor-promoting phorbol diesters. Toxicology (1981) 0.75
Management of the pregnant patient with carcinoma of the breast. Surg Gynecol Obstet (1990) 0.75
Parallel orders of reactivity in murine cells of mezerein and phorbol esters toward the mixed-lymphocyte response and promotion of tumorigenesis. Toxicol Appl Pharmacol (1981) 0.75
Cancer of the colon and rectum. A review. Postgrad Med (1975) 0.75
Studies on allotypes in sheep. Int Arch Allergy Appl Immunol (1972) 0.75
Thoracoscopy in acquired immunodeficiency syndrome. J Thorac Cardiovasc Surg (1997) 0.75
Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates. Surgery (1984) 0.75
Specific tumor immunity produced by the injection of vaccinia viral oncolysates. J Surg Res (1982) 0.75
[The treatment of advanced malignant melanoma with vaccina oncolysates (author's transl)]. Nouv Presse Med (1979) 0.75
Acute iron intoxication in an adult. JAMA (1974) 0.75
Coronary pseudoaneurysm after angioplasty. Am Surg (1995) 0.75
Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate. Ann Plast Surg (1992) 0.75
The effect of treatment with Corynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat. Acta Neuropathol (1985) 0.75
Reflections on my mentor, Felix Milgrom. Transplant Proc (1999) 0.75
Bedside percutaneous tracheostomy in acquired immunodeficiency syndrome. Am Surg (1998) 0.75
Survival after malignant melanoma in a black child. A case report and review of the literature. Am J Clin Oncol (1984) 0.75
Characterization of in vivo cross-reactive tumor resistance between two cultured murine colon lines. J Surg Res (1983) 0.75
Resection of metastatic colorectal cancer to the liver. Surgery (1981) 0.75
The role of tracheostomy in acquired immunodeficiency syndrome. Ann Thorac Surg (1997) 0.75
Monoclonal antibodies to the cell surface of a unique human lymphoid/myeloid cell line detect epitopes absent from peripheral blood mononuclear cells. Transplant Proc (1997) 0.75
A new approach in the immunotherapy of carcinoma of the colon and rectum. J Surg Oncol (1980) 0.75
Serum fucose as a monitor for recurrent malignancy. J Surg Oncol (1978) 0.75